NCT00611910View on ClinicalTrials.gov

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions

PHASE4CompletedINTERVENTIONAL
Enrollment

610

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Arteriosclerosis of Arterial Coronary Artery Bypass Graft
Interventions
DEVICE

sirolimus-eluting stent

due to randomization Cypher stent will be implanted

DEVICE

paclitaxel-eluting stent

due to randomization Taxus stent will be implanted

DEVICE

biodegradable-polymer-based sirolimus-eluting stent

due to randomization a rapamycin-eluting stent with biodegradable polymer will be implanted

DEVICE

bare metal stents

Due to randomization one bare-metal stent will be implanted. The decision about the stent type will be up to the interventionalist

Trial Locations (4)

80636

Deutsches Herzzentrum Muenchen, Munich

81675

Medizinische Klinik, Klinikum rechts der Isar, München

Unknown

Herzzentrum Bad Krozingen, Bad Krozingen

Bad Segeberger Kliniken, Bad Segeberg

All Listed Sponsors
lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00611910 - Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions | Biotech Hunter | Biotech Hunter